H2-Pharma

Montgomery, United States Founded: 2013 • Age: 13 yrs Acquired By ANI Pharmaceuticals
Distributor of generic pharmaceutical drugs

About H2-Pharma

H2-Pharma is a company based in Montgomery (United States) founded in 2013 was acquired by ANI Pharmaceuticals in February 2016.. H2-Pharma offers products and services including Branded Pharmaceuticals, Generic Pharmaceuticals, and Non-Rx Products. H2-Pharma operates in a competitive market with competitors including AmerisourceBergen, Pfizer, CHEPLAPHARM, Entero Healthcare and EBOS Group, among others.

  • Headquarter Montgomery, United States
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name H2-Pharma, Llc
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    ANI Pharmaceuticals

    (Feb 01, 2016)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of H2-Pharma

H2-Pharma offers a comprehensive portfolio of products and services, including Branded Pharmaceuticals, Generic Pharmaceuticals, and Non-Rx Products. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Sales and distribution of branded medications for various health needs.

Affordable alternatives for branded drugs in the pharmaceutical market.

Distribution of non-prescription health products to customers.

Funding Insights of H2-Pharma

  • Total Funding
  • Total Rounds 1
  • Last Round
  • First Round
  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Oct, 2020 Amount Seed - H2-Pharma Valuation Ardian
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in H2-Pharma

H2-Pharma has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include ANI Pharmaceuticals and Ardian. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
Private investment firm specializing in markets and partnerships.
Founded Year Domain Location
Branded and generic prescription drugs are developed, manufactured, and marketed.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by H2-Pharma

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - H2-Pharma

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

H2-Pharma Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of H2-Pharma

H2-Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AmerisourceBergen, Pfizer, CHEPLAPHARM, Entero Healthcare and EBOS Group, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Pharmaceutical distribution and supply chain services are provided globally.
domain founded_year HQ Location
Pharmaceutical products for treating multiple diseases are provided.
domain founded_year HQ Location
Branded pharmaceutical products are developed, marketed, and distributed globally.
domain founded_year HQ Location
India's leading healthcare products distribution platform
domain founded_year HQ Location
Wholesaler & distributor of healthcare, medical, and pharmaceutical products
domain founded_year HQ Location
Diversified drugs are distributed by Renee in the United States.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on H2-Pharma

Frequently Asked Questions about H2-Pharma

When was H2-Pharma founded?

H2-Pharma was founded in 2013 and raised its 1st funding round 7 years after it was founded.

Where is H2-Pharma located?

H2-Pharma is headquartered in Montgomery, United States. It is registered at Montgomery, Alabama, United States.

Who is the current CEO of H2-Pharma?

Brooke Cantey is the current CEO of H2-Pharma.

What does H2-Pharma do?

H2-Pharma was founded in 2013 and is headquartered in Montgomery, United States. Operations center on the distribution of generic pharmaceutical drugs within the healthcare sector. Supplies are provided to pharmacies, hospitals, and other providers across various markets. The company is led by Brooke Cantey, serving as CEO and President. Its online presence is maintained through the domain h2-pharma.com, supporting logistical and informational needs.

Who are the top competitors of H2-Pharma?

H2-Pharma's top competitors include Pfizer, Entero Healthcare and AmerisourceBergen.

What products or services does H2-Pharma offer?

H2-Pharma offers Branded Pharmaceuticals, Generic Pharmaceuticals, and Non-Rx Products.

Who are H2-Pharma's investors?

H2-Pharma has 2 investors. Key investors include ANI Pharmaceuticals, and Ardian.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available